adalimumab,ustekinumab
janssen,abbvie
['crohn', 'ibd', 'adalimumab']
the opening lecture of #ecco23 sees david rubin give an overview of treatment sequencing for patients with moderate-to-severe crohn s disease #ibd #gitwitter 
The Lancet Gastroenterology & Hepatology is the world-leading #gastroenterology and #hepatology research journal. IF=45.042. #Lancet200